Anesthetic management of patients with spinocerebellar ataxia type 2. A case report
Keywords:
spinocerebellar ataxia, anesthetic management, monitoringAbstract
Introduction: spinocerebellar ataxia type 2 is an autosomal dominant inherited disease in which degeneration of the cerebellum and its afferent and efferent pathways occurs and is characterized by ataxia, dysarthria, dysmetria, adiadochokinesia, action tremor, painful muscle contractures, early neuropathy, nystagmus, pyramidal signs, and cognitive, sleep and autonomic disorders.Patient information: anesthetic management is reported in a patient in which the main implications of anesthesia are related to neuromuscular degeneration and the possible occurrence of respiratory complications.
Conclusions: the adequate selection of anesthetic agents, the use of non-depolarizing muscle relaxants in reduced doses, epidural anesthesia combined with general anesthesia, early removal of the endotracheal tube or laryngeal mask, early mobilization and neuromuscular and cardiorespiratory monitoring are the fundamental elements in the anesthetic management of this patient.
Downloads
References
1.Velázquez Pérez L. Nueva era en las investigaciones e intervención sobre la ataxia espinocerebelosa tipo 2. CCM [Internet]. 2015 [citado 06/04/2020];19(4):598-601. Disponible en: http://scielo.sld.cu/scielo.php?script=sci_arttext&pid=S1560-43812015000400001
2.Velázquez Pérez L, Rodríguez Labrada R, Sánchez Cruz G, Laffita Mesa JM, Almaguer Mederos L, Aguilera Rodríguez R, et als. Caracterización integral de la ataxia espinocerebelosa 2 en Cuba y su aplicación en proyectos de intervención. Rev Cubana Salud Pública [Internet]. 2011 [citado 06/04/2020];37(3):230-244. Disponible en: http://scielo.sld.cu/scielo.php?script=sci_arttext&pid=S0864-34662011000300006
3.Lang AE. Otros trastornos del movimiento. En: Goldman L, Schafer AI. Goldman-Cecil Tratado de Medicina Interna. 25 ed. Barcelona: Elsevier; 2017. p. 2461-2470.
4.Velázquez Pérez LC, Rodríguez Labrada R, Fernández Ruiz J. Spinocerebellar Ataxia type 2: clinicogenetic aspects, mechanistic insights and management approaches. Front Neurol [Internet]. 2017 [citado 06/04/2020];8:472. Disponible en: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5601978/. https://doi.org/10.3389/fneur.2017.00472
5.Carrera González A, Llamos Paneque A, Montúfar Armendáriz S, Recalde M, Garzón M, Tambaco N, et al. Ataxia Espinocerebelosa tipo 2: diagnóstico clínico y molecular de dos casos atendidos en el Hospital de Especialidades de las Fuerzas Armadas No 1. Rev Med Vozandes [Internet]. 2017 [citado 06/04/2020];28(1):39-44. Disponible en: https://docs.bvsalud.org/biblioref/2019/03/986899/08_2017_rc02.pdf
6.Martínez Guerrero J, Paz Gutiérrez J, Vega Goxiola SB. Ataxia espinocerebelosa tipo 2. Arch Neurocien Mex [Internet]. 2016 [citado 08/04/2020];21(1):73-79. Disponible en: https://www.medigraphic.com/pdfs/arcneu/ane-2016/ane161h.pdf
7.Rodríguez Díaz JC, Velázquez Pérez L, Rodríguez Labrada R, Aguilera Rodríguez R, Laffita Pérez D, Canales Ochoa N, et al. Neurorehabilitation therapy in spinocerebellar ataxia type 2: a 24-week, rater-blinded, randomized, controlled trial. Mov Disord [Internet]. 2018 [citado 08/04/2020];33(9):1481-1487. Disponible en: https://pubmed.ncbi.nlm.nih.gov/30132999/. https://doi.org/10.1002/mds.27437
8.Velázquez Pérez L, Rodríguez Díaz JC, Rodríguez Labrada R, Medrano Montero J, Aguilera Cruz AB, Reynaldo Cejas L, et al. Neurorehabilitation improves the motor features in prodromal SCA2: a randomized, controlled trial. Mov Disord [Ìnternet]. 2019 [citado 08/04/2020];34(7):1060-1068. Disponible en: https://pubmed.ncbi.nlm.nih.gov/30958572/. https://doi.org/10.1002/mds.27676
9.Pasternak JJ, Lanier WL Jr. Spinal cord disorders. En: Hines RL, Marschall KE. Stoelting's Anesthesia and Co-Existing Disease. 7th ed. Philadelphia: Elsevier; 2017. p. 305-314.
10.Bordes C, Altamirano G, Arteaga D, Sorribes V, Roldan J. Manejo anestésico de la Atáxia de Friedreich. A propósito de un caso. XIV Congrés de la Societat Catalana d'Anestesiología, Reanimació i Terapèutica del Dolor [Internet]. Madrid: SEDAR; 2018 [citado 06/04/2020]. Disponible en: http://www.congresscartd.org/web2018/pdfs/abstracts/abstracts-com-poster-36.pdf
11.Özgül Ü. Anaesthesia recommendations for patients suffering from Friedreich's Ataxia. Orphananesthesia [Internet]. París: Orphanet; 2016 [citado 06/04/2020]. Disponible en: https://www.orphananesthesia.eu/en/rare-diseases/published-guidelines/friedreich-s-ataxia/257-friedreich%E2%80%99s-ataxia/file.html
12.Gordo Gómez YM, Ramírez Guerra DM, Rodríguez Labrada R, Velázquez Pérez LC. Alteraciones respiratorias de la Ataxia Espinocerebelosa Tipo 2: de las bases fisiopatológicas a su impacto en la neurorrehabilitación. CCM [Internet]. 2018 [citado 06/04/2020];22(1):115-128. Disponible en: http://scielo.sld.cu/scielo.php?script=sci_arttext&pid=S1560-43812018000100010
13.Perouansky M, Pearce RA, Hemmings HC Jr. Anestésicos inhalatorios. Mecanismo de acción. En: Miller RD. Miller Anestesia. 8a ed. Barcelona: Elseivier; 2016. p. 614-637e5.
14.Asencio Paris A, Cassinello Ogea C, Gil Bona J, Laglera Trebol S. Manejo anestésico del paciente con enfermedad cardiaca y respiratoria. En: Montero Matamala, A. 100 preguntas claves en Anestesiología y Reanimación. 2da ed. Barcelona: Permanyer; 2015. p. 47-52.
15.Rodríguez Díaz JC, Rodríguez Labrada R, Aguilera Rodríguez R, Ortega Sánchez R, Vázquez Mojena Y, Torres Vega R, el al. Reducción de la fuerza muscular en la ataxia espinocerebelosa tipo 2 y su relación con el tamaño de la mutación. Anales de la ACC [Internet]. 2020 [citado 06/04/2020];10(1):52-58. Disponible en: http://www.revistaccuba.cu/index.php/revacc/article/view/748/759
Downloads
Published
How to Cite
Issue
Section
License
Authors who have publications with this journal agree to the following terms:
- Authors will retain their copyright and assign to the journal the right of first publication of their work, which will simultaneously be subject to a Creative Commons License / Attribution-Noncommercial 4.0 International (CC BY-NC 4.0) that allows third parties to share the work as long as its author and first publication in this journal are indicated.
- Authors may adopt other non-exclusive license agreements for distribution of the published version of the work (e.g., depositing it in an institutional repository or publishing it in a monographic volume) as long as the initial publication in this journal is indicated.
- Authors are allowed and encouraged to disseminate their work through the Internet (e.g., in institutional telematic archives or on their web page) before and during the submission process, which can produce interesting exchanges and increase citations of the published work. (See The effect of open access).